4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one

C76H74N22O8 — CID 158698000

IUPAC4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one
SMILESC=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(-c4nc5ccccc5o4)cc3)c3c(N)n[nH]c(=O)c32)C1.C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(-n4cc5ccccc5n4)cc3)c3c(N)n[nH]c(=O)c32)C1.C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(C(=O)N4CCCC4)cc3)c3c(N)n[nH]c(=O)c32)C1
InChIInChI=1S/C26H24N8O2.C26H23N7O3.C24H27N7O3/c1-2-21(35)32-13-5-7-19(15-32)34-24-22(25(27)28-29-26(24)36)23(31-34)16-9-11-18(12-10-16)33-14-17-6-3-4-8-20(17)30-33;1-2-20(34)32-13-5-6-17(14-32)33-23-21(24(27)29-30-25(23)35)22(31-33)15-9-11-16(12-10-15)26-28-18-7-3-4-8-19(18)36-26;1-2-18(32)30-13-5-6-17(14-30)31-21-19(22(25)26-27-23(21)33)20(28-31)15-7-9-16(10-8-15)24(34)29-11-3-4-12-29/h2-4,6,8-12,14,19H,1,5,7,13,15H2,(H2,27,28)(H,29,36);2-4,7-12,17H,1,5-6,13-14H2,(H2,27,29)(H,30,35);2,7-10,17H,1,3-6,11-14H2,(H2,25,26)(H,27,33)/t19-;2*17-/m111/s1
InChIKeyIHEMAVXFBMIXDG-VFROHXCPSA-N
MW1423.57 g/mol
LogP8.54
Rot. Bonds12

About 4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one

4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one (PubChem CID 158698000) has the molecular formula C76H74N22O8 and a molecular weight of 1423.57 g/mol. Its IUPAC name is 4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one.

Molecular Properties

Compound Name4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one
PubChem CID158698000
Molecular FormulaC76H74N22O8
Molecular Weight1423.57 g/mol
Exact Mass1422.61
IUPAC Name4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one
SMILESC=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(-c4nc5ccccc5o4)cc3)c3c(N)n[nH]c(=O)c32)C1.C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(-n4cc5ccccc5n4)cc3)c3c(N)n[nH]c(=O)c32)C1.C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(C(=O)N4CCCC4)cc3)c3c(N)n[nH]c(=O)c32)C1
InChIInChI=1S/C26H24N8O2.C26H23N7O3.C24H27N7O3/c1-2-21(35)32-13-5-7-19(15-32)34-24-22(25(27)28-29-26(24)36)23(31-34)16-9-11-18(12-10-16)33-14-17-6-3-4-8-20(17)30-33;1-2-20(34)32-13-5-6-17(14-32)33-23-21(24(27)29-30-25(23)35)22(31-33)15-9-11-16(12-10-15)26-28-18-7-3-4-8-19(18)36-26;1-2-18(32)30-13-5-6-17(14-30)31-21-19(22(25)26-27-23(21)33)20(28-31)15-7-9-16(10-8-15)24(34)29-11-3-4-12-29/h2-4,6,8-12,14,19H,1,5,7,13,15H2,(H2,27,28)(H,29,36);2-4,7-12,17H,1,5-6,13-14H2,(H2,27,29)(H,30,35);2,7-10,17H,1,3-6,11-14H2,(H2,25,26)(H,27,33)/t19-;2*17-/m111/s1
InChIKeyIHEMAVXFBMIXDG-VFROHXCPSA-N
XLogP8.54
TPSA393.86 Ų
H-Bond Donors6
H-Bond Acceptors23
Rotatable Bonds12
Heavy Atoms106
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001423.57
LogP ≤ 58.54
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one?
The IUPAC name of 4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one (CID 158698000) is 4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one.
What is the SMILES notation for 4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one?
The canonical SMILES for 4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one is C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(-c4nc5ccccc5o4)cc3)c3c(N)n[nH]c(=O)c32)C1.C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(-n4cc5ccccc5n4)cc3)c3c(N)n[nH]c(=O)c32)C1.C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(C(=O)N4CCCC4)cc3)c3c(N)n[nH]c(=O)c32)C1.
What is the InChIKey of 4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one?
The InChIKey is IHEMAVXFBMIXDG-VFROHXCPSA-N. The full InChI is InChI=1S/C26H24N8O2.C26H23N7O3.C24H27N7O3/c1-2-21(35)32-13-5-7-19(15-32)34-24-22(25(27)28-29-26(24)36)23(31-34)16-9-11-18(12-10-16)33-14-17-6-3-4-8-20(17)30-33;1-2-20(34)32-13-5-6-17(14-32)33-23-21(24(27)29-30-25(23)35)22(31-33)15-9-11-16(12-10-15)26-28-18-7-3-4-8-19(18)36-26;1-2-18(32)30-13-5-6-17(14-30)31-21-19(22(25)26-27-23(21)33)20(28-31)15-7-9-16(10-8-15)24(34)29-11-3-4-12-29/h2-4,6,8-12,14,19H,1,5,7,13,15H2,(H2,27,28)(H,29,36);2-4,7-12,17H,1,5-6,13-14H2,(H2,27,29)(H,30,35);2,7-10,17H,1,3-6,11-14H2,(H2,25,26)(H,27,33)/t19-;2*17-/m111/s1.
What are the key properties of 4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one?
4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one has a molecular weight of 1423.57 g/mol, XLogP of 8.54, 12 rotatable bonds, 6 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 4-amino-3-[4-(1,3-benzoxazol-2-yl)phenyl]-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-3-(4-indazol-2-ylphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-6H-pyrazolo[4,5-d]pyridazin-7-one;4-amino-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]-3-[4-(pyrrolidine-1-carbonyl)phenyl]-6H-pyrazolo[4,5-d]pyridazin-7-one is sourced from PubChem (CID 158698000), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).